Literature DB >> 33085862

Sensory Ganglionopathy.

Anthony A Amato1, Allan H Ropper1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33085862     DOI： 10.1056/NEJMra2023935

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.

Authors:  Kevin A Strauss; Michelle A Farrar; Francesco Muntoni; Kayoko Saito; Jerry R Mendell; Laurent Servais; Hugh J McMillan; Richard S Finkel; Kathryn J Swoboda; Jennifer M Kwon; Craig M Zaidman; Claudia A Chiriboga; Susan T Iannaccone; Jena M Krueger; Julie A Parsons; Perry B Shieh; Sarah Kavanagh; Sitra Tauscher-Wisniewski; Bryan E McGill; Thomas A Macek
Journal:  Nat Med       Date:  2022-06-17       Impact factor: 87.241

Review 2.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

Review 3.  Recessive cerebellar and afferent ataxias - clinical challenges and future directions.

Authors:  Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 42.937

4.  Progressive sensory ataxia and breast implant rupture, an uncommon presentation of a debated concept: a case report.

Authors:  Sofie Van Assche; Heleen Parmentier; Gaelle Varkas; Isabelle Peene; Sarah Herdewyn
Journal:  BMC Neurol       Date:  2022-09-24       Impact factor: 2.903
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.